LAM RESEARCH CORP (LRCX) Stock Analyst Ratings
NASDAQ:LRCX - Nasdaq - US5128073062 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 81% to LRCX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 91.39. This target is 11.09% above the current price.
LRCX was analyzed by 36 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about LRCX.
In the previous month the buy percentage consensus was at a similar level.
LRCX was analyzed by 36 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-24 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-04-24 | Needham | Maintains | Buy -> Buy |
| 2025-04-24 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-24 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-04-24 | TD Securities | Maintains | Buy -> Buy |
| 2025-04-24 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-22 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-16 | B of A Securities | Maintains | Buy -> Buy |
| 2025-04-15 | Stifel | Maintains | Buy -> Buy |
| 2025-04-14 | UBS | Maintains | Buy -> Buy |
| 2025-04-11 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-03-28 | Jefferies | Maintains | Buy -> Buy |
| 2025-02-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-02-20 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-02-20 | Susquehanna | Upgrade | Neutral -> Positive |
| 2025-02-18 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-01-30 | Cantor Fitzgerald | Upgrade | Neutral -> Overweight |
| 2025-01-30 | Needham | Reiterate | Buy -> Buy |
| 2025-01-30 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-17 | Keybanc | Upgrade | Sector Weight -> Overweight |
| 2025-01-17 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-15 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2025-01-13 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-10 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-01-10 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-12-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-12-05 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-29 | Bernstein | Maintains | Market Perform -> Market Perform |
| 2024-10-24 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2024-10-24 | Needham | Reiterate | Buy -> Buy |